Switching from clopidogrel to prasugrel in patients having coronary stent implantation

Journal of Thrombosis and Thrombolysis

Volumn 38, Issue 3, 2014, Pages 395-401

  Parodi, Guido ^a   De Luca, Giuseppe ^b   Bellandi, Benedetta ^a   Comito, Vincenzo ^a   Valenti, Renato ^a   Marcucci, Rossella ^c   Carrabba, Nazario ^a   Migliorini, Angela ^a   Ramazzotti, R N Erica ^a   Gensini, Gian Franco ^c,d   Abbate, Rosanna ^c   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Acute coronary syndromes; Bleeding; Prasugrel; Stent; Switching

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIRULOG; HISTAMINE H2 RECEPTOR ANTAGONIST; PRASUGREL; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR; PIPERAZINE DERIVATIVE; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE; TICLOPIDINE;

AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART REINFARCTION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG SUBSTITUTION; MIDDLE AGED; STENT; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; DRUG SUBSTITUTION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PIPERAZINES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RENAL INSUFFICIENCY, CHRONIC; SEX FACTORS; STENTS; THIOPHENES; THROMBOSIS; TICLOPIDINE;

EID: 84906933740     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1040-7     Document Type: Article

References (25)

1. Wiviott SD, Trenk D, Frelinger AL, PRINCIPLE-TIMI 44 Investigators et al (2007) Prasugrel compared with high loading- and maintenance-dose clopidogrel in patientswith planned percutaneous coronary intervention: the Prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial. Circulation 116:2923-2932 (Pubitemid 350291199)
2. Wiviott SD, Antman EM, Winters KJ, JUMBO-TIMI 26 Investigators et al (2005) Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the joint utilization of medications to block platelets optimally (JUMBO)-TIMI 26 trial. Circulation 111:3366-3373 (Pubitemid 40931949)
3. Wiviott SD, Braunwald E, McCabe CH (2007) TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001-2015 (Pubitemid 350106708)
4. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501-2555
5. Levine GN, Bates ER, Blankenship JC, ACCF, AHA, SCAI Practice Guidelines et al (2011) ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary (2011). A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 124:2574-2609
6. Wiviott SD, Braunwald E, Angiolillo DJ, TRITON-TIMI 38 investigators et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. Circulation 118:1626-1636
7. Murphy SA, Antman EM, Wiviott SD et al (2008) Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. Eur Heart J 29:2473-2479
8. Wiviott SD, Braunwald E, McCabe CH, TRITON-TIMI 38 investigators et al (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371:1353-1363
9. Migliorini A, Valenti R, Marcucci R et al (2009) High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Circulation 120:2214-2221
10. Parodi G, Bellandi B, Venditti F et al (2012) Residual platelet reactivity, bleedings and adherence to treatment in patients having coronary stent implantation treated with prasugrel. Am J Cardiol 109:214-218
11. Parodi G, Marcucci R, Valenti R et al (2011) Association between high residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing percutaneous coronary intervention. JAMA 306:1215-1223
12. Erlinge D, Gurbel PA, James S et al (2013) Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: the generations trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. J Am Coll Cardiol 1097:2161-2162
13. Erlinge D, Ten Berg J, Foley D et al (2012) Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the feather trial. J Am Coll Cardiol 60:2032-2040
14. The TIMI study group (1985) The thrombolysis in myocardial infarction trial. N Engl J Med 31:932-936
15. Mehran R, Rao SV, Bhatt DL et al (2011) Standardized bleeding definitions for cardiovascular clinical trials. A consensus report from the bleeding academic research consortium. Circulation 123:2736-2747
16. Roe MT, Armstrong PW, Fox KA, TRILOGY ACS Investigators et al (2012) Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. New Engl J Med 367:1297-1309
17. Small DS, Farid NA, Payne CD et al (2008) Effects of proton pump inhibitors lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol 48:475-484 (Pubitemid 351389118)
18. Azmoon S, Angiolillo D (2012) Switching antiplatelets regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI. Cath Cardiovasc Interv 81:232-242
19. Brandt JT, Payne CD, Wiviott SD et al (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153(66):9-16
20. Payne CD, Li YG, Brandt JT et al (2008) Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. Platelets 19:275-281 (Pubitemid 351874155)
21. Angiolillo DJ, Saucedo JF, Deraad R, SWAP Investigators et al (2010) Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study. J Am Coll Cardiol 56:1017-1023
22. Montalescot G, Sideris G, Cohen R et al (2010) Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 103:213-223
23. Diodati JD, Fung A, Saucedo JF et al (2012) Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients: the TRIPLET trial. Can J Cardiol 28:S377 724 Abstract
24. Loh JP, Pendyala LK, Kitabata H et al (2013) Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 111:841-845
25. Trenk D, Stone GW, Gawaz M et al (2012) A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug eluting stents. J Am Coll Cardiol 59:2159-2164